Aubrey Capital Management LTD Staar Surgical CO Transaction History

Aubrey Capital Management LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	SELL	$46.82 - $76.2 $145,142 - $236,220	-3,100 Reduced 4.73%	62,400 $3.03 Million
Q2 2022 Aug 16, 2022	BUY	$50.24 - $80.48 $507,424 - $812,848	10,100 Added 18.23%	65,500 $4.65 Million
Q1 2022 May 05, 2022	BUY	$57.98 - $93.5 $602,992 - $972,400	10,400 Added 23.11%	55,400 $4.43 Million
Q3 2021 Nov 05, 2021	BUY	$122.75 - $162.68 $1.09 Million - $1.45 Million	8,900 Added 24.65%	45,000 $5.78 Million
Q2 2021 Aug 12, 2021	BUY	$105.76 - $154.96 $3.82 Million - $5.59 Million	36,100 New	36,100 $5.51 Million
Q4 2018 Feb 13, 2019	SELL	$28.91 - $50.0 $2.24 Million - $3.88 Million	-77,500 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$13.95 - $32.65 $1.08 Million - $2.53 Million	77,500 New	77,500 $0

255

47.8M

427K

206K

Ticker STAA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 48,038,300
Market Cap $1.28B
Description
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...

Get notified when there are updates to the investment portfolio of Aubrey Capital Management LTD, based on Form 13F filings with the SEC.

Stay updated on Aubrey Capital Management LTD with notifications on news.